// App-Quantinova.ai

LBP14 : Noncontrast CT vs. CTA Source Imaging - Which Modality Better Predicts Clinical Outcomes After IA Therapy? A Post Hoc Analysis of the Penumbra START Trial

Researchers

Presenter

  • Donald Frei

Principal Investigators

  • Elad Levy

  • Qaisar Shah

  • Ferdinand Hui

  • Mayank Goyal

  • Basavaraj Ghodke

  • Ali Shaibani

  • Mark Harrigan

  • Tudor Jovin

  • Michael Madison

  • Zeshan Chaudhry

  • Frank Hellinger II

  • Ramon Gonzalez

  • Leticia Barraza

  • Arani Bose

  • Siu Po Sit

  • Vance McCollom

  • David Fiorella

  • Aquilla Turk III

  • Tim Malisch

  • Osama Zaidat

  • Michael Alexander

  • Thomas Devlin

Medical Centers

  • Massachusetts General Hospital, Boston, MA

  • Northwest Community Hosp, Arlington Heights, IL

  • Alexian Brothers Medical Ctr, Elk Grove, IL

  • Swedish Med Cntr, Englewood, CO

  • Penumbra Inc., Alameda, CA

  • St. Paul Radiology, St. Paul, MN

  • Alberta Health Services, Calgary, AB, Canada

  • Chattanooga Ctr for Neurologic Res, Chattanooga, TN

  • Cleveland Clinic, Cleveland, OH

  • The Medical College of Wisconsin, Milwaukee, WI

  • University of Alabama at Birmingham, Birmingham, AL

  • Abington Memorial Hospital, Abington, PA

  • Medcl Univ of South Carolina, Charleston, SC

  • Cedars-Sinai Medical Center, Los Angeles, CA

  • Florida Hospial, Orlando, FL

  • Mercy Womens Center, Oklahoma City, OK

  • UPMC Health System, Pittsburg, PA

  • Kaleida Health, Buffalo, NY

  • Harborview Medical Center, Seattle, WA

  • Forsyth Medical Center, Winston-Salem, NC

  • Stony Brook Univ Medcl Ctr, Stonybrook, NY

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Ischemic stroke

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • single arm

  • double blind/blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim